These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 23947381)
1. Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum. Dubois AV; Midoux P; Gras D; Si-Tahar M; Bréa D; Attucci S; Khelloufi MK; Ramphal R; Diot P; Gauthier F; Hervé V Am J Respir Crit Care Med; 2013 Sep; 188(6):703-9. PubMed ID: 23947381 [TBL] [Abstract][Full Text] [Related]
2. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum. Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221 [TBL] [Abstract][Full Text] [Related]
3. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis. Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747 [TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients. Hansen G; Hoffjan S; Mosler K; Schuster A Lung; 2001; 179(3):185-94. PubMed ID: 11891608 [TBL] [Abstract][Full Text] [Related]
5. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients. Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321 [TBL] [Abstract][Full Text] [Related]
6. Polysulfated Hyaluronan GlycoMira-1111 Inhibits Elastase and Improves Rheology in Cystic Fibrosis Sputum. Kummarapurugu AB; Zheng S; Pulsipher A; Savage JR; Ma J; Rubin BK; Kennedy TP; Voynow JA Am J Respir Cell Mol Biol; 2021 Feb; 64(2):260-267. PubMed ID: 33264072 [TBL] [Abstract][Full Text] [Related]
7. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658 [TBL] [Abstract][Full Text] [Related]
8. Effect of cystic fibrosis exacerbations on neutrophil function. Brockbank S; Downey D; Elborn JS; Ennis M Int Immunopharmacol; 2005 Mar; 5(3):601-8. PubMed ID: 15683855 [TBL] [Abstract][Full Text] [Related]
9. [An alpha 1-antitrypsin aerosol in the treatment of cystic fibrosis]. Ferrer Calvete J; Aznar Lucea J; Morales Marín P; Pereda Pérez A; Llopis Carles R; Ribes Koninckx C; Ferrer González P; Marco Martínez V An Esp Pediatr; 1996 Feb; 44(2):109-11. PubMed ID: 8830566 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of neutrophil elastase in CF sputum by L-658,758. Rees DD; Brain JD; Wohl ME; Humes JL; Mumford RA J Pharmacol Exp Ther; 1997 Dec; 283(3):1201-6. PubMed ID: 9399994 [TBL] [Abstract][Full Text] [Related]
11. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. Palmer KL; Aye LM; Whiteley M J Bacteriol; 2007 Nov; 189(22):8079-87. PubMed ID: 17873029 [TBL] [Abstract][Full Text] [Related]
12. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. Döring G; Frank F; Boudier C; Herbert S; Fleischer B; Bellon G J Immunol; 1995 May; 154(9):4842-50. PubMed ID: 7722333 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease. Taylor-Cousar JL; Wiley C; Felton LA; St Clair C; Jones M; Curran-Everett D; Poch K; Nichols DP; Solomon GM; Saavedra MT; Accurso FJ; Nick JA J Cyst Fibros; 2015 Mar; 14(2):228-36. PubMed ID: 25466700 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum. Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923 [TBL] [Abstract][Full Text] [Related]
16. Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties. Lecaille F; Naudin C; Sage J; Joulin-Giet A; Courty A; Andrault PM; Veldhuizen RA; Possmayer F; Lalmanach G Int J Biochem Cell Biol; 2013 Aug; 45(8):1701-9. PubMed ID: 23707200 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation. Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270 [TBL] [Abstract][Full Text] [Related]
18. Faster, higher, stronger. Rubin BK Am J Respir Crit Care Med; 2013 Sep; 188(6):634-5. PubMed ID: 24032379 [No Abstract] [Full Text] [Related]
19. Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum. Venaille TJ; Ryan G; Robinson BW Respir Med; 1998 Feb; 92(2):233-40. PubMed ID: 9616518 [TBL] [Abstract][Full Text] [Related]
20. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]